FDEIX
Price
$25.66
Change
-$0.06 (-0.23%)
Updated
Jun 5 closing price
Net Assets
5.1B
VIVIX
Price
$66.84
Change
-$0.13 (-0.19%)
Updated
Jun 5 closing price
Net Assets
188.77B
Interact to see
Advertisement

FDEIX vs VIVIX

Header iconFDEIX vs VIVIX Comparison
Open Charts FDEIX vs VIVIXBanner chart's image
Fidelity Advisor Capital Development I
Price$25.66
Change-$0.06 (-0.23%)
VolumeN/A
Net Assets5.1B
Vanguard Value Index I
Price$66.84
Change-$0.13 (-0.19%)
VolumeN/A
Net Assets188.77B
FDEIX vs VIVIX Comparison Chart
Loading...
View a ticker or compare two or three
VS
FDEIX vs. VIVIX commentary
Jun 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FDEIX is a Buy and VIVIX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VIVIX has more cash in the bank: 189B vs. FDEIX (5.1B). VIVIX pays higher dividends than FDEIX: VIVIX (2.29) vs FDEIX (0.85). FDEIX was incepted earlier than VIVIX: FDEIX (20 years) vs VIVIX (27 years). FDEIX (0.68) is less costly to investors than VIVIX (0.04). FDEIX is a more actively managed with annual turnover of: 16.00 vs. VIVIX (9.00). FDEIX has a lower initial minimum investment than VIVIX: FDEIX (0) vs VIVIX (5000000). FDEIX annual gain was more profitable for investors over the last year : 9.00 vs. VIVIX (6.89). FDEIX return over 5 years is better than : 82.19 vs. VIVIX (58.98).
FDEIXVIVIXFDEIX / VIVIX
Total Expense Ratio0.680.041,700%
Annual Report Gross Expense Ratio0.680.041,700%
Fund Existence20 years27 years-
Gain YTD6.8991.452475%
Front LoadN/AN/A-
Min. Initial Investment05000000-
Min. Initial Investment IRAN/AN/A-
Net Assets5.1B189B3%
Annual Yield % from dividends0.852.2937%
Returns for 1 year9.006.89131%
Returns for 3 years39.9320.06199%
Returns for 5 years82.1958.98139%
Returns for 10 years82.79103.6380%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
HGHRX33.36N/A
N/A
Hartford Healthcare R3
PRCOX59.39N/A
N/A
T. Rowe Price U.S. Equity Research
MGLAX16.39N/A
N/A
MFS Global Real Estate A
JARIX15.34N/A
N/A
Easterly Global Real Estate I
KNGCX11.55N/A
N/A
Vest S&P500 Div Aristocrats Trgt Inc C